The Academy of Finland’s Research Council for Health has decided to fund ten new research posts as Academy Research Fellow, following the review of applications submitted in the Academy’s September 2014 call.
In the call, the Research Council received 87 applications for Academy Research Fellow funding. The success rate was slightly over 11 per cent. According to reviewer feedback, the applications submitted were high-quality, the best ones internationally competitive.
The aim of the five-year funding for a research post as Academy Research Fellow is to provide an opportunity for the most talented and advanced researchers to develop their skills of academic leadership and to establish themselves as independent researchers.
Examples of funding recipients:
Retirement is an important life transition. Just as health can affect decisions about retirement, retirement can affect health and health behaviour. Sari Stenholm (University of Turku) aims to study how health behaviour and clinical risk factors change around the time of retirement by following ageing workers during their retirement transition. The study will also examine how life-long health behaviour is associated with extended working-life participation and what are the consequences of extended working life on physical and cognitive functioning in old age. Such information could be used at the individual and population level to promote health and functional capacity later in life.
Cancer therapy is changing from a “one drug fits all” approach to providing more individualised forms of therapy. Mikko Anttonen (Helsinki University Central Hospital) and his research team aim to introduce a molecularly defined approach into treatment strategies of ovarian and endometrial cancer. The team has vast experience in modelling the genetically stable and molecularly defined ovarian granulosa cell tumour (GCT). It will use that experience to introduce individualised systems medicine to identify tools that may guide the treatment selection by gynaecologic oncology teams. The aim is to identify novel biomarkers to predict and monitor the efficiency of targeted treatments. The team will institute new evidence-based guidelines for diagnostic evaluation, treatment planning and follow-up of GCTs.
Dementia and Alzheimer disease prevention is a major public health priority. Alina Solomon’s (University of Eastern Finland) project focuses on formulating tools for identifying high-risk individuals who may benefit from preventive interventions. The research will benefit from novel computer-based methods for analysis and visualization of a broad range of dementia-related factors and biomarkers. The project’s aim is to produce comprehensive profiling tools that can facilitate personalisation of preventive strategies in order to make them more effective.
- Science Adviser Heikki Vilen, tel. +358 295 335 135, firstname.lastname(at)aka.fi
- List of funding recipients
Academy of Finland Communications
tel. +358 295 335 131